Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
Western blot analysis of HER-4 was performed by loading 25 ug of mouse brain cell lysates onto an SDS polyacrylamide gel. Proteins were transferred to a PVDF membrane and blocked at 4°C overnight. The membrane was probed with a HER-4 monoclonal antibody (Product # MA5-13016) at a dilution of 1:100 overnight at 4°C, washed in TBST, and probed with an HRP-conjugated secondary antibody for 1 hr at room temperature in the dark. Chemiluminescent detection was performed using Pierce ECL Plus Western Blotting Substrate (Product # 32132). Results show a band at ~180kDa.
|Tested species reactivity||Human|
|Published species reactivity||Ferret, Rat, Human|
|Host / Isotype||Mouse / IgG2a|
|Immunogen||Extracellular domain of recombinant human c-erbB-4/HER-4 oncoprotein|
|Storage buffer||PBS, pH 7.4, with 0.2% BSA|
|Contains||0.09% sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||Assay Dependent|
|Western Blot (WB)||1:50-1:500|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (IHC)||See 2 publications below|
|Blocking Assay (BLOCK)||See 9 publications below|
|Immunocytochemistry (ICC)||See 3 publications below|
|Western Blot (WB)||See 1 publications below|
|Immunoprecipitation (IP)||See 1 publications below|
|Flow Cytometry (Flow)||See 1 publications below|
MA5-13013 targets HER-4 in WB and FACS applications and shows reactivity with Human samples.
The MA5-13013 immunogen is extracellular domain of recombinant human c-erbB-4/HER-4 oncoprotein.
c-erbB-4 is the fourth member of class I receptor kinase family (ErbB). HER-4 is most predominantly expressed in several breast carcinoma cell lines, and in normal skeletal muscle, heart, pituitary, brain, and cerebellum. Breast tumor cell lines T47-D, MDA-MB-453, BT-474 and H3396 are found to have the highest levels of mRNA, and intermediate levels are seen in MCF-7, MDA-MB-330 and MDA-MB-361. Expression of erbB-4 is low or absent in some breast tumor cell lines such as MDA-MB-231, MDA-MB-157, MDA-MB-468, and SKBR-3
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Immunohistochemical analysis of the monoclonal antibody 4B5 in breast tissue expressing human epidermal growth factor receptor 4 (HER4).
MA5-13013 was used in immunohistochemistry to study the utility of the 4B5 monoclonal antibody for clinical HER2 status determination in breast tissue expressing HER4
|Jay JI,Brunhoeber PS,Smith MH,Williams RR,Sugarman MC,Free HL,Tast DE||Histopathology (62:563)||2013|
Neuregulin directly decreases voltage-gated sodium current in hippocampal ErbB4-expressing interneurons.
MA5-13013 was used in immunohistochemistry to study the direct effects of neuregulin on voltage-gated sodium channel activity of hippocampal interneurones expressing ErbB4
|Janssen MJ,Leiva-Salcedo E,Buonanno A||The Journal of neuroscience : the official journal of the Society for Neuroscience (32:13889)||2012|
Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma.
MA5-13013 was used in blocking or activating experiment to study the mechanisms underlying the modulation of neuroblastoma cellular stress and chemoresistance by HER4
|Hua Y,Gorshkov K,Yang Y,Wang W,Zhang N,Hughes DP||Cancer (118:5140)||2012|
Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissue.
MA5-13013 was used in blocking or activating experiment to study the role of decorin in suppressing semaphorin 3A expression within adult rat cerebral cortex scar tissue
|Minor KH,Bournat JC,Toscano N,Giger RJ,Davies SJ||Brain : a journal of neurology (134:1140)||2011|
Heparin-binding epidermal growth factor-like growth factor is a potent neurotrophic factor for PC12 cells.
MA5-13013 was used in blocking or activating experiment to investigate the effect of heparin-binding epidermal growth factor-like growth factor on neuronal functions
|Zhou Y,Besner GE||Neuro-Signals (18:141)||2011|
Populations of radial glial cells respond differently to reelin and neuregulin1 in a ferret model of cortical dysplasia.
MA5-13013 was used in blocking or activating experiment to investigate the influence of reelin and NRG1 on radial glia cells in ferrets
|Poluch S,Juliano SL||PloS one (5:null)||2010|
Diminished survival of human cytotrophoblast cells exposed to hypoxia/reoxygenation injury and associated reduction of heparin-binding epidermal growth factor-like growth factor.
MA5-13013 was used in blocking or activating experiment to study the role of HB-EGF as a survival factor in human cytotrophoblast cells exposed to hypoxia/reoxygenation injury
|Leach RE,Kilburn BA,Petkova A,Romero R,Armant DR||American journal of obstetrics and gynecology (198:471.e1)||2008|
Epidermal growth factor-like growth factors prevent apoptosis of alcohol-exposed human placental cytotrophoblast cells.
MA5-13013 was used in blocking or activating experiment to examine the anti-apoptotic effect of epidermal growth factor-like growth factors in human placental cytotrophoblast cells
|Wolff GS,Chiang PJ,Smith SM,Romero R,Armant DR||Biology of reproduction (77:53)||2007|
ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy.
MA5-13013 was used in blocking or activating experiment and immunohistochemistry to study the role and therapeutic potential of ErbB4 in non-small-cell lung cancer
|Starr A,Greif J,Vexler A,Ashkenazy-Voghera M,Gladesh V,Rubin C,Kerber G,Marmor S,Lev-Ari S,Inbar M,Yarden Y,Ben-Yosef R||International journal of cancer (119:269)||2006|
Human trophoblast survival at low oxygen concentrations requires metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor.
MA5-13013 was used in blocking or activating experiment to study the role of metalloproteinase-mediated shedding of HB-EGF-like growth factor in human trophoblast survival at low oxygen concentrations
|Armant DR,Kilburn BA,Petkova A,Edwin SS,Duniec-Dmuchowski ZM,Edwards HJ,Romero R,Leach RE||Development (Cambridge, England) (133:751)||2006|
Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells.
MA5-13013 was used in blocking or activating experiment to investigate the mechanism of MMP9 induction by betacellulin in head-and-neck squamous carcinoma cells
|O-charoenrat P,Wongkajornsilp A,Rhys-Evans PH,Eccles SA||International journal of cancer (111:174)||2004|
Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth.
MA5-13013 was used in immunocytochemistry to investigate the role of Stat3 in the tumorigenic effect of heregulin/ErbB-2 in breast cells
|Proietti CJ,Rosemblit C,Beguelin W,Rivas MA,Díaz Flaqué MC,Charreau EH,Schillaci R,Elizalde PV||Molecular and cellular biology (29:1249)||2009|
Regulation of ErbB-4 endocytosis by neuregulin in GABAergic hippocampal interneurons.
MA5-13013 was used in immunocytochemistry to study the role of neuregulin in modulating ErbB4 endocytosis in cultured hippocampal neurons
|Longart M,Chatani-Hinze M,Gonzalez CM,Vullhorst D,Buonanno A||Brain research bulletin (73:210)||2007|
Neuregulin expression, function, and signaling in human ovarian cancer cells.
MA5-13013 was used in immunocytochemistry to investigate the characteristics of neuregulin in human ovarian cancer cells
|Gilmour LM,Macleod KG,McCaig A,Sewell JM,Gullick WJ,Smyth JF,Langdon SP||Clinical cancer research : an official journal of the American Association for Cancer Research (8:3933)||2002|
Isolation of scFvs to in vitro produced extracellular domains of EGFR family members.
MA5-13013 was used in western blot to develop and characterize specific antibodies targeting EGFR family
|Horak E,Heitner T,Robinson MK,Simmons HH,Garrison J,Russeva M,Furmanova P,Lou J,Zhou Y,Yuan QA,Weiner LM,Adams GP,Marks JD||Cancer biotherapy & radiopharmaceuticals (20:603)||2005|
An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis.
MA5-13013 was used in immunoprecipitation to study the effect of an epidermal growth factor receptor inhibibor on HB-EGF activity and apoptosis
|Mahtouk K,Jourdan M,De Vos J,Hertogh C,Fiol G,Jourdan E,Rossi JF,Klein B||Blood (103:1829)||2004|
Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
MA5-13013 was used in flow cytometry to investigate the regulation of matrix metalloproteinase 9 by epidermal growth factor-like ligands in head and neck squamous carcinoma cells
|O-charoenrat P,Modjtahedi H,Rhys-Evans P,Court WJ,Box GM,Eccles SA||Cancer research (60:1121)||2000|
avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4; ERBB4 transcript variant I12DEL; ERBB4 transcript variant I20DEL; human epidermal growth factor receptor 4; proto-oncogene-like protein c-ErbB-4; receptor tyrosine-protein kinase erbB-4; tyrosine kinase-type cell surface receptor HER4; v-erb-a erythroblastic leukemia viral oncogene homolog 4; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4
ALS19; ERBB4; HER4; p180erbB4